These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5888534)

  • 1. [The effect of pentacin (CaNa3 DTPA) on copper elimination in patients with chronic lead poisoning].
    Dashash A; Panfilova IK
    Gig Tr Prof Zabol; 1965 Jul; 9(7):46-9. PubMed ID: 5888534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Routes of elimination of lead in patients with chronic lead poisoning under the effect of complexon therapy with pentacin (CaNa3 DTPA)].
    Iampol'skaia BA; Dashash A
    Gig Tr Prof Zabol; 1968 Mar; 12(3):54-6. PubMed ID: 5729191
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ca-DTPA in the treatment of chronic lead poisoning].
    De Bruin J
    Ned Tijdschr Geneeskd; 1967 May; 111(18):824-6. PubMed ID: 6042305
    [No Abstract]   [Full Text] [Related]  

  • 4. [CHANGES IN THE IRON CONTENT OF BLOOD AND URINE IN PATIENTS WITH LEAD POISONING TREATED WITH COMPLEXION THERAPY (PENTACIN--CANA3 DTPA)].
    DASHASH A
    Gig Tr Prof Zabol; 1964 Dec; 8():12-6. PubMed ID: 14306658
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of osmotic diuresis and pentacin (CaNa3 DTPA) on the distribution in the organism, and renal excretion of Cr51, Mn54, Co57, Fe59, Cu64, Zn65 and Mo99].
    Koval' IuF; Kondrashev VM
    Gig Tr Prof Zabol; 1968 Dec; 12(12):28-30. PubMed ID: 5731072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lead poisoning--a current industrial risk].
    Swensson A
    Lakartidningen; 1968 Feb; 65(7):673-81. PubMed ID: 4972783
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the chelating action of CaDTPA Na3 (trisodic and monocalcic salt of ethylen-triaminopentacetic acid) in experimental and human saturnism and in compairison with the action of CaEDTANa2].
    Rossi A
    Folia Med (Napoli); 1967 Jan; 50(1):39-51. PubMed ID: 4972289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Research in the complexon series. I. Detoxicant capacity of Ca-DTPA in experimental chronic plutonium poisoning in rats. II. Influence of the repeated intravenous administration of Ca-DTPA on the elimination of trace elements in rats. 3. Preliminary results of the study, in rats, of the modalities of calcium elimination after Ca45-DTPA injection].
    Truhaut R; Boudène C; Lutz M
    Ann Biol Clin (Paris); 1966; 24(3):419-39. PubMed ID: 5932716
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical value of the DTPA test in chronic lead poisoning].
    Kieć E; Antczak K
    Med Pr; 1967; 18(1):70-4. PubMed ID: 4963090
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of pentacin (DTPA) in deposition of Ce144 in lung tissue].
    Borisov VP; Korolev GK
    Med Radiol (Mosk); 1967 Feb; 12(2):79-81. PubMed ID: 5616164
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of polymeric 239Pu removal by liposome-encapsulated pentacin].
    Smirnov AA; Altukhova GA; Beliaev IK; Ivannikov AT; Il'in LA
    Radiobiologiia; 1984; 24(3):386-9. PubMed ID: 6739746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion by tetrameric catechoylamide ligands and CaNa3-DTPA of the dissociation in vitro of the Pu-transferrin complex formed after intravenous injection of Pu-tri-N-butylphosphate.
    Metivier H; Masse R; Durbin PW; Raymond KN
    Health Phys; 1985 Dec; 49(6):1302-5. PubMed ID: 3841100
    [No Abstract]   [Full Text] [Related]  

  • 13. Chelation of cadmium from metallothionein in vivo and its excretion in rats repeatedly injected with cadmium chloride.
    Cherian MG; Rodgers K
    J Pharmacol Exp Ther; 1982 Sep; 222(3):699-704. PubMed ID: 7108771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined reticuloendothelial stimulation and long-term, intermittent DTPA therapy in poisoning by polymeric plutonium. ANL-7409.
    Rosenthal MW; Smoler HM; Lindenbaum A
    ANL Rep; 1967; ():180. PubMed ID: 5308231
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cobalt and copper salts on the toxic action of lead on the animal organism].
    Chaĭka PA
    Vopr Pitan; 1968; 27(6):29-33. PubMed ID: 5739836
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some features of cardiovascular diseases caused by exposure to lead and copper compounds].
    Gudzovskiĭ GA; Minaev BD; Malykhin FT; Golodnikov IuN
    Med Tr Prom Ekol; 2004; (8):32-6. PubMed ID: 15490626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple system involvement in chronic lead poisoning.
    Marcus SM
    Vet Hum Toxicol; 1981 Dec; 23(6):424-5. PubMed ID: 7336566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the comparative efficacy of desferrioxamine and DTPA as agents for the elimination of plutonium in poisoned rats].
    Truhaut R; Boudène C; Lutz M; Métivier H
    Arch Mal Prof; 1966 Sep; 27(9):669-76. PubMed ID: 5983123
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of corticosteroid hormones on erythropoiesis in toxic lead anemia].
    Makotchenko VM
    Probl Gematol Pereliv Krovi; 1972 Nov; 17(11):57-60. PubMed ID: 4668041
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognosis of chronic lead poisoning. Comment on the article from DMW 43/2001].
    Hagemeyer O
    Dtsch Med Wochenschr; 2003 Nov; 128(45):2388. PubMed ID: 14606039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.